The real value of all Indian airlines put together: Re 1
UBS removes Sun Pharma, adds Dr Reddy's to model portfolio

Corporate Aug 6, 2012

Sun Pharma to consider internal restructuring of business

Drug major Sun Pharma said its board will meet later this week to consider internal restructuring of the business and to announce first quarter results.

The Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August "would consider the internal restructuring of the business of the company with effect from 31 March, 2012".

.Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade. Reuters

The board will also announce the financial results of the company for the first quarter ended 30 June, 2012. The board would also consider declaration of the interim dividend of Rs 4.25 per share of Re 1 each on equity shares of the company for the year ended March 31, 2012, the filing said.

Shares of Sun Pharma were trading at Rs 670.30 on the BSE in the afternoon trade, up 1.55 percent from its previous close.

PTI

Related Stories.